Centene (CNC) is a publicly traded Healthcare sector company. As of May 20, 2026, CNC trades at $58.02 with a market cap of $28.75B and a P/E ratio of -4.53. CNC moved -1.98% today. Year to date, CNC is +41.57%; over the trailing twelve months it is -3.90%. Its 52-week range spans $25.08 to $75.35. Analyst consensus is buy with an average price target of $51.80. Rallies surfaces CNC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Centene Buy Rating Raised, Target Jumps to $80 on 2028 Earnings Outlook: Analysts upgraded Centene to Buy from Hold and raised its price target from $53 to $80, valuing shares at 12 times projected 2028 earnings of $6.70 per share. The outlook reflects expected margin recovery after cost pressures ease, driven by peaked healthcare utilization and disciplined underwriting.
| Metric | Value |
|---|---|
| Price | $58.02 |
| Market Cap | $28.75B |
| P/E Ratio | -4.53 |
| EPS | $-13.05 |
| Dividend Yield | 0.00% |
| 52-Week High | $75.35 |
| 52-Week Low | $25.08 |
| Volume | 1.29M |
| Avg Volume | 0 |
| Revenue (TTM) | $198.10B |
| Net Income | $-6.45B |
| Gross Margin | 7.36% |
16 analysts cover CNC: 0 strong buy, 6 buy, 9 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $51.80.